Goldman Sachs leads a $110M Series C into compliance-critical AI decisioning as Qualcomm acquires Modular for $4B — institutional capital is picking sides. Today's briefing covers regulated fintech AI, healthcare data infrastructure, enterprise agent governance, and European sovereign compute.
Audio is available on Spreaker — see link below.
Goldman Sachs just led a hundred-and-ten million dollar Series C into a company that automates credit underwriting, fraud detection, and AML decisions inside regulated banks. That's the signal that matters today.
The same logic is driving Qualcomm's roughly four billion dollar acquisition of Modular. Qualcomm is a semiconductor company buying an AI inference software stack.
In healthcare, a similar thesis is playing out, just with different vocabulary. Assort Health raised a hundred-and-twenty million dollars, led by Menlo and Lightspeed, to scale AI agents across patient-journey workflows.
Two smaller rounds are worth holding onto because of what they signal about where the production AI stack is heading. Runlayer raised thirty million in a Felicis-led Series A to build a control layer for distributed enterprise AI agents.
Outside the US, TensorX launched in Dublin and Helsinki with eight million euros and a plan to deploy a hundred million euros in Blackwell GPU capacity targeting regulated European sectors. The round is small.
The broader pattern across today's deals is the crossover of institutional capital into venture-stage AI infrastructure. Goldman, BlackRock, UBS, and Aramco are appearing alongside traditional software VCs in these rounds.
Chapter summary auto-generated from the verified script. Listen to the full episode for the complete content.